Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome J Wang, D Wu, H Guo, M Li Life sciences 236, 116940, 2019 | 262 | 2019 |
Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS) Y Li, C Chen, Y Ma, J Xiao, G Luo, Y Li, D Wu Life sciences 228, 167-175, 2019 | 158 | 2019 |
FGFR-TKI resistance in cancer: current status and perspectives S Yue, Y Li, X Chen, J Wang, M Li, Y Chen, D Wu Journal of hematology & oncology 14, 1-14, 2021 | 100 | 2021 |
LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance D Wu, M Guo, X Min, S Dai, M Li, S Tan, G Li, X Chen, Y Ma, J Li, L Jiang, ... Chemical Communications 54 (85), 12089-12092, 2018 | 59 | 2018 |
Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen D Wu, DT Gallagher, R Gowthaman, BG Pierce, RA Mariuzza Nature communications 11 (1), 2908, 2020 | 54 | 2020 |
Structure of the forkhead domain of FOXA2 bound to a complete DNA consensus site J Li, AC Dantas Machado, M Guo, JM Sagendorf, Z Zhou, L Jiang, X Chen, ... Biochemistry 56 (29), 3745-3753, 2017 | 51 | 2017 |
The role of mTOR in ovarian neoplasms, polycystic ovary syndrome, and ovarian aging J Liu, DC Wu, LH Qu, HQ Liao, MX Li Clinical Anatomy 31 (6), 891-898, 2018 | 47 | 2018 |
Association of luteinizing hormone/choriogonadotropin receptor gene polymorphisms with polycystic ovary syndrome risk: a meta-analysis J Zou, D Wu, Y Liu, S Tan Gynecological Endocrinology 35 (1), 81-85, 2019 | 42 | 2019 |
Association of PD-L1 gene rs4143815 C> G polymorphism and human cancer susceptibility: A systematic review and meta-analysis J Zou, D Wu, T Li, X Wang, Y Liu, S Tan Pathology-Research and Practice 215 (2), 229-234, 2019 | 37 | 2019 |
Crystal structure of the FGFR4/LY2874455 complex reveals insights into the Pan-FGFR selectivity of LY2874455 D Wu, M Guo, MA Philips, L Qu, L Jiang, J Li, X Chen, Z Chen, L Chen, ... PLoS One 11 (9), e0162491, 2016 | 37 | 2016 |
Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors D Wu, A Kolesnikov, R Yin, JD Guest, R Gowthaman, A Shmelev, ... Nature Communications 13 (1), 19, 2022 | 30 | 2022 |
IL-37 as a potential biotherapeutics of inflammatory diseases J Bai, Y Li, M Li, S Tan, D Wu Current Drug Targets 21 (9), 855-863, 2020 | 30 | 2020 |
BDNF and nicotine dependence: associations and potential mechanisms Z Huang, D Wu, X Qu, M Li, J Zou, S Tan Reviews in the Neurosciences 32 (1), 79-91, 2021 | 16 | 2021 |
DNA-binding properties of FOXP3 transcription factor J Li, L Jiang, X Liang, L Qu, D Wu, X Chen, M Guo, Z Chen, L Chen, ... Acta biochimica et biophysica Sinica 49 (9), 792-799, 2017 | 15 | 2017 |
Systemic analysis of the DNA replication regulator MCM complex in ovarian cancer and its prognostic value Y Li, J Zou, Q Zhang, F Quan, L Cao, X Zhang, J Liu, D Wu Frontiers in Oncology 11, 681261, 2021 | 13 | 2021 |
Rapid cloning, expression and purification of a novel high-activity alkaline phosphatase with detoxification of lipopolysaccharide D Wu, D Teng, D Xi, X Wang, X Wang, R Mao, Y Zhang, H Dai, J Wang Process Biochemistry 49 (3), 402-408, 2014 | 13 | 2014 |
Saccharomyces boulardii prevention of the hepatic injury induced by Salmonella Enteritidis infection D Wu, D Teng, X Wang, C Dai, J Wang Canadian journal of microbiology 60 (10), 681-686, 2014 | 12 | 2014 |
T cell receptors employ diverse strategies to target a p53 cancer neoantigen D Wu, R Gowathaman, BG Pierce, RA Mariuzza Journal of Biological Chemistry 298 (3), 2022 | 10 | 2022 |
Nogo‑B receptor in relevant carcinoma: Current achievements, challenges and aims YK Li, YJ Xie, DC Wu, SL Long, S Tang, ZC Mo International Journal of Oncology 53 (5), 1827-1835, 2018 | 10 | 2018 |
Characterization of ibrutinib as a non-covalent inhibitor of SRC-family kinases M Guo, S Dai, D Wu, Y Duan, J Li, L Qu, L Jiang, Z Chen, X Chen, Y Chen Bioorganic & Medicinal Chemistry Letters 34, 127757, 2021 | 7 | 2021 |